vusolimogene,rp12146,tenalisib
incozen therapeutics,rhizen,replimune
['rp12146', 'solid tumor', 'rp1', 'breast', 'tenalisib', 'rhizen']
rhizen pharmaceuticals ag announces upcoming data presentations at esmo 2022 for its clinical stage assets; tenalisib in locally advanced/ metastatic breast cancer and rp12146 in multiple solid tumors 
?? ?? ??? ?????? ?? ??? ???? ?????. ?????? ?? ????? ??? ??, ??? ???? ???? ??????. ???? 02-737-3600 help@newswire.co.kr  
https://t.co/hoFZSRmNgz